Agomab

Senior Project Toxicologist

Agomab  •  Kingdom of Belgium (Onsite)  •  2 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Senior Project Toxicologist

Department: Development

Employment Type: Permanent - Full Time

Location: Agomab Antwerp

Description

The Senior Project Toxicologist leads non-clinical safety within cross-functional drug development teams, from candidate selection through clinical development. This strategic role shapes safety strategy, establishes company positions for global health-authority interactions and informs external-asset and business development decisions.

Key Responsibilities

  • Own non-clinical safety strategy and, under the development project leader, work with cross-functional stakeholders to deliver an integrated development strategy.
  • Develop and adapt phase-appropriate non-clinical and regulatory toxicology plans, with clear objectives, decision points, timelines, budgets and risk mitigation aligned with project priorities.
  • Design and oversee outsourced toxicology and safety pharmacology studies, ensuring data and reports meet requirements from candidate selection through first-in-human, early efficacy and late-stage clinical development, as applicable.
  • Integrate toxicology, safety pharmacology, DMPK, bioanalytical and translational evidence to assess human relevance, target-organ risks and clinical mitigation. Advise project teams, senior management and governance bodies on benefit–risk and development decisions.
  • Define and communicate the company’s non-clinical safety positions in global health-authority submissions and interactions, including IBs, DSURs, INDs and scientific advice briefing books.
  • Evaluate external assets and in-licensing opportunities, contributing safety assessments to due diligence, asset valuation and deal recommendations.
  • Strengthen the preclinical safety function in line with scientific, quality and compliance standards.

Skills, Knowledge and Expertise

  • PhD, DVM, PharmD or equivalent advanced degree in toxicology, pharmacology, pathology, biomedical sciences or a related discipline, with required postdoctoral or specialist toxicology training.
  • DABT, ERT or equivalent internationally recognised toxicology credential strongly preferred.
  • At least 15 years’ progressive experience in pharmaceutical or biotechnology R&D non-clinical safety, regulatory toxicology or integrated safety assessment, including substantial programme- or portfolio-level responsibility.
  • Proven non-clinical safety leadership across drug development stages in both clinical-stage biotech and mature pharmaceutical organisations, with the ability to adapt to entrepreneurial and matrixed environments.
  • Expert knowledge of FDA, EMA and ICH expectations, GLP and integrated safety assessment; able to translate evolving guidance into proportionate, risk-based plans.
  • Proactive, solution-oriented and results-driven, with strong analytical, planning and organisational skills and a collaborative, network-building approach.
  • Excellent communication skills and fluency in written and spoken English.
  • Leadership competencies: integrates complex evidence into clear, accountable risk-based recommendations; constructively challenges assumptions, aligns stakeholders and influences senior decisions; upholds scientific, strategic, quality and ethical standards, communicates uncertainty transparently and champions safety concerns.

What we offer

  • A high-impact role in an ambitious, innovation-driven biotech company.
  • Direct involvement in pioneering therapies for unmet medical needs.
  • A collaborative, agile and fast-paced environment.
  • A role based in Antwerp, Belgium, with remote-working options tailored to your needs.
  • Competitive salary and benefits.
Agomab

About Agomab

Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases.

Industry
Biotech & Life Sciences
Company Size
51-200 employees
Headquarters
Antwerp, BE
Year Founded
2017
Social Media